100 YEARS OF VITAMIN D: Light and health: a century after the therapeutic use of UV light and vitamin D, hormones advanced medical care J Köhrle, M Rauner, SA Lanham-New Endocrine Connections 11 (1), 2022 | 4 | 2022 |
11 Spurenelemente und Mineralstoffe J Köhrle, L Schomburg, K Schümann | | |
3-Iodothyronamine decreases expression of genes involved in iodide metabolism in mouse thyroids and inhibits iodide uptake in PCCL3 thyrocytes N Schanze, SF Jacobi, E Rijntjes, S Mergler, M Del Olmo, CS Hoefig, ... Thyroid 27 (1), 11-22, 2017 | 23 | 2017 |
3-iodothyronamine differentially modulates− 2A-adrenergic receptor-mediated signaling J Dinter, J Muhlhaus, SF Jacobi, CL Wienchol, M Coster, J Meister J Mol Endocrinol 54 (3), 205-216, 2015 | 63 | 2015 |
3-Iodothyronamine increases transient receptor potential melastatin channel 8 (TRPM8) activity in immortalized human corneal epithelial cells A Lucius, N Khajavi, PS Reinach, J Köhrle, P Dhandapani, P Huimann, ... Cellular signalling 28 (3), 136-147, 2016 | 50 | 2016 |
3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism I Lehmphul, CS Hoefig, J Köhrle Molecular and cellular endocrinology 460, 219-228, 2018 | 13 | 2018 |
3-iodothyronamine—a thyroid hormone metabolite with distinct target profiles and mode of action J Köhrle, H Biebermann Endocrine reviews 40 (2), 602-630, 2019 | 42 | 2019 |
3,5-Diiodo-L-Thyronine (3,5-T2) Exerts Thyromimetic Effects on Hypothalamus-Pituitary-Thyroid Axis, Body Composition, and Energy Metabolism in Male Diet … W Jonas, J Lietzow, F Wohlgemuth, CS Hoefig, P Wiedmer, U Schweizer, ... Endocrinology 156 (1), 389-399, 2015 | 101 | 2015 |
3, 5-T2 alters murine genes relevant for xenobiotic, steroid, and thyroid hormone metabolism J Lietzow, J Golchert, G Homuth, U Völker, W Jonas, J Köhrle Journal of molecular endocrinology 56 (4), 311-323, 2016 | 33 | 2016 |
3, 5-T2-an endogenous thyroid hormone metabolite as promising lead substance in anti-steatotic drug development? R Sane, EK Wirth, J Köhrle Metabolites 12 (7), 582, 2022 | 4 | 2022 |
3, 5-T2-an Endogenous Thyroid Hormone Metabolite as Promising Lead Substance in Anti-Steatotic Drug Development? Metabolites 2022, 12, 582 R Sane, EK Wirth, J Köhrle s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
3, 5-T2—a Janus-faced thyroid hormone metabolite exerts both canonical T3-mimetic endocrine and intracrine hepatic action J Köhrle, I Lehmphul, M Pietzner, K Renko, E Rijntjes, K Richards, ... Frontiers in Endocrinology 10, 787, 2020 | 19 | 2020 |
4-methylbenzylidene-camphor (4MBC) causes effects comparable to primary hypothyroidism I Gotthardt, C Schmutzler, P Kirschmeyer, W Wuttke, H Jarry, J Köhrle Experimental and Clinical Endocrinology & Diabetes 115 (S 1), P02_014, 2007 | 8 | 2007 |
4-methylbenzylidene-camphor (4MBC) causes pituitary effects comparable to hypothyroidism IH Hamann, C Schmutzler, P Kirschmeyer, H Jarry, J Köhrle Endocrine Abstracts 11, 2006 | 3 | 2006 |
4MBC and OMC, components of UV-sunscreens, exert organ specific alterations on type I 5'-Deiodinase activity and expression in female rats I Hamann, P Hofmann, C Schmutzler, B Mentrup, K Huhne, H Jarry, ... Experimental and Clinical Endocrinology & Diabetes 113 (S 1), 138, 2005 | 4 | 2005 |
5′-Deiodination in rat hepatocytes: Effects of specific flavonoid inhibitors M SPANKA, RD HESCH, K IRMSCHER, J KÖHRLE Endocrinology 126 (3), 1660-1667, 1990 | 33 | 1990 |
55th Mosbach Colloquium: How nutrients influence gene activity R Brigelius-Flohé, J Köhrle Biol. Chem 385, 569, 2004 | | 2004 |
71 Jodstoffwechsel und Schilddrüsenkrankheiten J Köhrle | | |
82nd Annual Meeting of the American Thyroid AssociationMEETING ABSTRACTS & PROGRAM N Schoenmakers, B Bak, Y Sun, PVAN Trotsenburg, W Oostdijk, P Voshol, ... Thyroid (New York, NY) 22 (S1), A-1-A-124, 2012 | | 2012 |
86th Annual Meeting of the American Thyroid Association KB Buddhdev, A Patel, P Xiao, C Guda, J Baker, W Goldner, J Rodiger, ... Thyroid (New York, NY) 26 (S1), P-1-A-129, 2016 | 1 | 2016 |